I offered some tips to help reboot your sleep health. That list still contains my top tips. But this year, I want to add to ...

A new review highlights the future of anti-obesity medications that could outperform today's already blockbuster drugs like ...

The use of GLP-1 drugs sparked the term "Ozempic shaming" to describe the negative perceptions faced by those who choose medical interventions for weight management. Some critics argue that using the ...

The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.

Citi downgraded telehealth company Hims & Hers Health (NYSE:HIMS) to Sell from Neutral and upgraded value-based care provider agilon health (NYSE:AGL) to Neutral from Sell on Friday as part of its ...

As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...

Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss ...

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

According to BMO Capital Markets, Medicare coverage of Lilly’s Zepbound opens the door to using secondary indications to ...

In a rare case, a recipient of a donated organ died of cancer after contracting the illness from the donor. Doctors said the unnamed patient from Arizona underwent an organ transplant to treat his ...

This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...